Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobradex AF Ocular Penetration in Cataract Surgery
NCT00473070Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Nov 2006
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tobradex AF in post-operative ocular inflammation, ocular infection, sponsored by Alcon Inc.. Started Nov 2006; status: completed.
02
Drugs
Tobradex AF
03
Conditions
post-operative ocular inflammationocular infection
Beyond the preview
Go deeper on NCT00473070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473070.